Awards & Advancement

Garland joins Exelixis

Tuesday, October 25, 2011 12:52 PM

Exelixis has named J. Scott Garland as executive vice president and chief commercial officer. As the company's chief commercial officer, Gardland will oversee the commercial functions of marketing, sales and commercial operations, and collaborate closely with Exelixis' development and manufacturing teams to provide commercial perspective for cabozantinib development efforts across multiple oncology indications.

More... »

NERI receives $45 million grant to support Pediatric Heart Network

Tuesday, October 25, 2011 10:44 AM

New England Research Institutes (NERI) has received a $45 million grant from the National Institutes of Health (NIH) for the continuance of its work on the Pediatric Heart Network (PHN). PHN is a multi-center clinical research network started in 2001, supported by the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health, to study congenital and acquired heart diseases that occur in childhood. This grant provides five more years of funding to nine clinical centers and NERI as the data coordinating center, to conduct clinical research studies in children and young adults with heart defects and other heart diseases.

More... »

Metabolomx awarded $1.14 million grant from NCI

Monday, October 24, 2011 01:34 PM

Metabolomx, a diagnostic company focused on breath analysis for the detection of cancer, has been awarded a Small Business Innovation Research (SBIR) contract by the National Cancer Institute (NCI). The $1.14 million combined phase I/II Fast-Track contract will support the research and development of Metabolomx' sensor array system to detect lung cancer.

More... »

Sanofi names Meeker CEO of Genzyme

Monday, October 24, 2011 01:18 PM

Sanofi has named David Meeker as chief executive officer of Genzyme, a Sanofi company, effective November 1, 2011. He will report to Christopher A. Viehbacher, chief executive officer of Sanofi, and will join the group management committee. Viehbacher will retain the position of chairman, Genzyme.

More... »

GenoLogics secures $8 million in strategic financing

Friday, October 21, 2011 02:14 PM

GenoLogics has raised $8 million in strategic financing led by new investor Illumina. The financing will be used to accelerate product development for future clinical applications and new desktop sequencing systems, and to expand sales and marketing functions.

More... »

ICON receives contract award from FNIH

Friday, October 21, 2011 01:38 PM

ICON has received a contract award from the Foundation for the National Institutes of Health (FNIH) to provide clinical support for the Biomarkers Consortium study entitled Characterization of the Variability of Insulin Secretory Parameters in the Meal Tolerance and the Maximal Stimulation Tests of Healthy Subjects. 

More... »

goBalto secures Series A financing

Thursday, October 20, 2011 11:51 AM

goBalto, developer of new generation web-based clinical research solutions, has raised an undisclosed amount in Series A financing from Silicon Valley-based health technology investors Aberdare Ventures and the West Health Investment Fund. The funds will be used to expand goBalto's corporate activities and to enhance Tracker, its Software-as-a-Service (SaaS) clinical trials platform that was launched in June 2011.

More... »

Proteostasis names Enyedy CEO

Thursday, October 20, 2011 10:27 AM

Proteostasis Therapeutics has named Mark J. Enyedy chief executive officer. Enyedy joins Proteostasis after serving 15 years at Genzyme, most recently as president of the transplant, oncology and multiple sclerosis divisions. Enyedy has also been elected to the Proteostasis board of directors.

More... »

Imagen Biotech secures $40 million in Series A financing

Thursday, October 20, 2011 10:22 AM

Imagen Biotech has secured up to $40 million in Series A financing from SV Life Sciences, Novo Ventures, and Fidelity Biosciences to pursue the identification and development of breakthrough treatments for blinding diseases with high unmet medical needs, including dry age-related macular degeneration. Matthew Feinsod, MD, an ophthalmologist who was formerly at Eyetech Pharmaceuticals and a medical officer in the FDA's Ophthalmology Division, will lead these efforts as chief medical officer for Imagen. Additional terms will not be disclosed.

More... »

Amgen names executive VP

Wednesday, October 19, 2011 01:50 PM

Amgen has named Anthony (Tony) Hooper, executive vice president, global commercial operations, effective October 26th. In this role, Hooper will report to Robert A. Bradway, president and chief operating officer.

More... »